Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
6.21
-0.05 (-0.80%)
Feb 12, 2026, 11:46 AM EST - Market open
Zura Bio Employees
Zura Bio had 30 employees as of December 31, 2024. The number of employees increased by 15 or 100.00% compared to the previous year.
Employees
30
Change (1Y)
15
Growth (1Y)
100.00%
Revenue / Employee
n/a
Profits / Employee
-$2,084,000
Market Cap
457.56M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 30 | 15 | 100.00% | 30 | 0 |
| Dec 31, 2023 | 15 | - | - | 14 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 368 |
| ADC Therapeutics | 265 |
| 4D Molecular Therapeutics | 227 |
| Prothena Corporation | 163 |
| Invivyd | 100 |
| Ocugen | 95 |
| Verastem | 78 |
| Lineage Cell Therapeutics | 77 |
ZURA News
- 8 days ago - Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit - Business Wire
- 22 days ago - Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer - Business Wire
- 4 weeks ago - Zura Bio Reports Business Updates and Outlook for 2026 - Business Wire
- 3 months ago - Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates - Business Wire
- 6 months ago - Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference - Business Wire
- 6 months ago - Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates - Business Wire
- 7 months ago - Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 8 months ago - Zura Bio Announces Chief Financial Officer Transition - Business Wire